Oramed Pharma (ORMP) Operatsion marja

Ommaviy kompaniya oramed.com (ORMP) logotipi

GURU.Markets grafigidagi operatsion foyda marjasi (EBIT) samaradorlik dinamikasini namoyish etadi, bunda 0.00 ko'rsatkichning joriy qiymatini belgilaydi. Oramed Pharmaceuticals (ORMP) yordamchi biotexnologiya firmalariga investitsiya kiritish orqali ishlanish risklarini minimallashtiradi. Kapital millionlab diabetiklar uchun oral insulin yaratishga asoslangan. Biroq, flagman mahsuloti bilan bog'liq muvaffaqiyatsizliklardan so'ng investitsiyalarga strategik yo'nalishning o'zgarishi pul oqimini beqaror qilmoqda.

ORMP: Oramed Pharmaceuticals Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022 - 19.11.2026

Oramed (ORMP) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:oramed.com, ORMP
Oramed Pharmaceuticals Inc. asosiy tovari

Operatsion marja asosiy biznes jarayonlarining samaradorligini o'lchaydi va soliq majburiyatlari hamda qarz xarajatlari hisobga olinishidan oldin birlamchi operatsiyalardan olinadigan foyda ulushini belgilaydi. Foizlar va soliqlardan oldingi operatsion foyda darajasini tahlil qilish orqali investor Oramed Pharmaceuticals (ORMP) modelining haqiqiy hayotiy qobiliyatini ko'rishi mumkin, u hozirda yetarli naqd zaxiralarni saqlagan holda, dori vositalarini ishlab chiqish strategiyasidagi o'zgarishlardan keyingi turg'unlikni yengishga intilmoqda.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.